Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Feb;7(Suppl 1):S54-S56.
doi: 10.21037/tlcr.2018.01.13.

The risk of second primary lung cancer: an unsolved dilemma

Affiliations
Editorial

The risk of second primary lung cancer: an unsolved dilemma

Antoinette J Wozniak et al. Transl Lung Cancer Res. 2018 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

  • Risk Stratification for Second Primary Lung Cancer.
    Han SS, Rivera GA, Tammemägi MC, Plevritis SK, Gomez SL, Cheng I, Wakelee HA. Han SS, et al. J Clin Oncol. 2017 Sep 1;35(25):2893-2899. doi: 10.1200/JCO.2017.72.4203. Epub 2017 Jun 23. J Clin Oncol. 2017. PMID: 28644772 Free PMC article.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30. 10.3322/caac.21332 - DOI - PubMed
    1. Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 1998;90:1335-45. 10.1093/jnci/90.18.1335 - DOI - PubMed
    1. National Lung Screening Trial Research Team , Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409. 10.1056/NEJMoa1102873 - DOI - PMC - PubMed
    1. National Comprehensive Cancer Network. NCCN guidelines in oncology: lung cancer screening. Version 2. 2018. Available online: https://www.nccn.org/
    1. Han SS, Rivera GA, Tammemägi MC, et al. Risk Stratification for Second Primary Lung Cancer. J Clin Oncol 2017;35:2893-9. 10.1200/JCO.2017.72.4203 - DOI - PMC - PubMed

LinkOut - more resources